{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:26:02Z","timestamp":1790961962928,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bioadv.2022.213077","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T12:59:17Z","timestamp":1659704357000},"page":"213077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Advances in aptamer-based drug delivery vehicles for cancer therapy"],"prefix":"10.1016","volume":"140","author":[{"given":"Kousar","family":"Ghasemii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Darroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilnaz","family":"Rahimmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matineh","family":"Ghomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Hassanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeel","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satar","family":"Yousefiasl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zarrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Borzacchiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rabiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cl\u00e1udia","family":"Paiva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Rabiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2022.213077_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13046-022-02293-6","article-title":"Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response","volume":"41","author":"Ashrafizadeh","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioadv.2022.213077_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-022-01235-1","article-title":"The long and short non-coding RNAs modulating EZH2 signaling in cancer","volume":"15","author":"Mirzaei","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40097-019-00325-w","article-title":"Thymoquinone-loaded ethosome with breast cancer potential: optimization, in vitro and biological assessment","volume":"10","author":"Nasri","year":"2020","journal-title":"J. Nanostruct. Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40097-021-00399-5","article-title":"Milk protein-based nanodelivery systems for the cancer treatment","volume":"11","author":"Tavakoli","year":"2021","journal-title":"J. Nanostruct. Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101279","article-title":"Endocytosis of abiotic nanomaterials and nanobiovectors: inhibition of membrane trafficking","volume":"40","author":"Makvandi","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.bioadv.2022.213077_bb0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40097-021-00432-7","article-title":"Metal\u2013polymer-coordinated complexes as potential nanovehicles for drug delivery","volume":"11","author":"Tabasi","year":"2021","journal-title":"J. Nanostruct. Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40097-020-00344-y","article-title":"Thermodynamic studies of carbon nanotube interaction with gemcitabine anticancer drug: DFT calculations","volume":"10","author":"Najafi","year":"2020","journal-title":"J. Nanostructure Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0040","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1039\/D1NJ06145C","article-title":"Electroconductive and photoactive poly(phenylenediamine)s with antioxidant and antimicrobial activities for potential photothermal therapy","volume":"46","author":"Ghahremanloo","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118491","article-title":"Hyaluronic acid-based nanoplatforms for doxorubicin: a review of stimuli-responsive carriers, co-delivery and resistance suppression","volume":"272","author":"Ashrafizadeh","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2022.213077_bb0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.matt.2021.11.021","article-title":"Bioinspired microneedle patches: biomimetic designs, fabrication, and biomedical applications","volume":"5","author":"Makvandi","year":"2022","journal-title":"Matter"},{"key":"10.1016\/j.bioadv.2022.213077_bb0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mattod.2021.03.012","article-title":"Stimuli-responsive transdermal microneedle patches","volume":"47","author":"Makvandi","year":"2021","journal-title":"Mater. Today"},{"key":"10.1016\/j.bioadv.2022.213077_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102678","article-title":"Mesoporous bioactive glasses in cancer diagnosis and therapy: stimuli-responsive, toxicity, immunogenicity, and clinical translation","volume":"9","author":"Sharifi","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004014","article-title":"Drug delivery (Nano)Platforms for Oral and dental applications: tissue regeneration, infection control, and cancer management","volume":"8","author":"Makvandi","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.bioadv.2022.213077_bb0075","series-title":"TechConnect Briefs","first-page":"366","article-title":"Targeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study","volume":"2","author":"Basto","year":"2007"},{"key":"10.1016\/j.bioadv.2022.213077_bb0080","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/03007995.2017.1421528","article-title":"An overview on the current status of cancer nanomedicines","volume":"34","author":"Jabir","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bioadv.2022.213077_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/1061186X.2018.1491978","article-title":"Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles","volume":"27","author":"Zununi Vahed","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioadv.2022.213077_bb0090","first-page":"1","article-title":"Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery","volume":"22","author":"Rabiee","year":"2021","journal-title":"J. Nanostructure Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0095","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.3390\/ijms21239123","article-title":"Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy","volume":"22","author":"Fu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0100","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1039\/C5CS00645G","article-title":"Aptamer-integrated DNA nanostructures for biosensing, bioimaging and cancer therapy","volume":"45","author":"Meng","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioadv.2022.213077_bb0105","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.3390\/s150716281","article-title":"Nucleic acid aptamers: an emerging tool for biotechnology and biomedical sensing","volume":"15","author":"Ku","year":"2015","journal-title":"Sensors"},{"key":"10.1016\/j.bioadv.2022.213077_bb0110","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1039\/c4an00132j","article-title":"Aptamer-based biosensors for biomedical diagnostics","volume":"139","author":"Zhou","year":"2014","journal-title":"Analyst"},{"key":"10.1016\/j.bioadv.2022.213077_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.44","article-title":"Aptamer\u2013nanoparticle complexes as powerful diagnostic and therapeutic tools","volume":"48","author":"Jo","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bioadv.2022.213077_bb0120","series-title":"Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice","first-page":"361","article-title":"Aptamer detection of neurodegenerative diseaseneurodegenerative diseasesbiomarkersbiomarkers","author":"Xi","year":"2022"},{"key":"10.1016\/j.bioadv.2022.213077_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioadv.2022.213077_bb0130","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3390\/ijms18112430","article-title":"Nucleic acid aptamers: emerging applications in medical imaging, nanotechnology, neurosciences, and drug delivery","volume":"18","author":"R\u00f6thlisberger","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121751","article-title":"Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics","volume":"620","author":"Sheikh","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2022.213077_bb0140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/polym11091515","article-title":"Aptamer-functionalized liposomes as a potential treatment for basal cell carcinoma","volume":"11","author":"Cadinoiu","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.bioadv.2022.213077_bb0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ymthe.2020.01.012","article-title":"Targeting SOX2 protein with peptide aptamers for therapeutic gains against esophageal squamous cell carcinoma","volume":"28","author":"Liu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioadv.2022.213077_bb0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/1061186X.2018.1491978","article-title":"Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles","volume":"27","author":"Zununi Vahed","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioadv.2022.213077_bb0155","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2022.213077_bb0160","first-page":"1","article-title":"Cytotoxicity of aptamer-conjugated chitosan encapsulated mycogenic gold nanoparticles in human lung cancer cells","author":"Hu","year":"2021","journal-title":"J. Nanostructure Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101119","article-title":"Self-assembled peptide and protein nanostructures for anti-cancer therapy: targeted delivery, stimuli-responsive devices and immunotherapy","volume":"38","author":"Delfi","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.bioadv.2022.213077_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2018.09.011","article-title":"Aptamer-guided nanomedicines for anticancer drug delivery","volume":"134","author":"Alshaer","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2022.213077_bb0175","article-title":"Advances in the development of aptamer drug conjugates for targeted drug delivery, Wiley interdiscip","volume":"9","author":"Chen","year":"2017","journal-title":"Rev. Nanomed."},{"key":"10.1016\/j.bioadv.2022.213077_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/17425247.2019.1575808","article-title":"An exploration of aptamer internalization mechanisms and their applications in drug delivery","volume":"16","author":"Wan","year":"2019","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.bioadv.2022.213077_bb0185","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1248\/bpb.33.796","article-title":"Nucleolin on the cell surface as a new molecular target for gastric cancer treatment","volume":"33","author":"Watanabe","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioadv.2022.213077_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2021.686586","article-title":"Integrating wheat nucleolus structure and function: variation in the wheat ribosomal RNA and protein genes","volume":"12","author":"Appels","year":"2021","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0195","first-page":"224","article-title":"Distribution of BoLA-DRB3 allelic frequencies and identification of a new allele in the Iranian cattle breed sistani (Bos indicus)","volume":"45","author":"Mohammadi","year":"2009","journal-title":"Genetika"},{"key":"10.1016\/j.bioadv.2022.213077_bb0200","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.15537\/smj.2016.12.15972","article-title":"Roles of nucleolin. Focus on cancer and anti-cancer therapy","volume":"37","author":"Chen","year":"2016","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.bioadv.2022.213077_bb0205","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2174\/1567201815666180724104451","article-title":"Cell surface nucleolin as a promising receptor for effective AS1411 aptamer-mediated targeted drug delivery into cancer cells","volume":"15","author":"Mosafer","year":"2018","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.bioadv.2022.213077_bb0210","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1074\/jbc.M113.532580","article-title":"Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor","volume":"289","author":"Gupta","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0215","first-page":"43","article-title":"Aptamer-modified polymer nanoparticles for targeted drug delivery","volume":"17","author":"Modrejewski","year":"2016","journal-title":"Bio Nano Mater."},{"key":"10.1016\/j.bioadv.2022.213077_bb0220","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2022.213077_bb0225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/jacs.9b09782","article-title":"Precision-guided missile-like DNA nanostructure containing warhead and guidance control for aptamer-based targeted drug delivery into cancer cells in vitro and in vivo","volume":"142","author":"Ouyang","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2022.213077_bb0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejpb.2020.07.018","article-title":"Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma","volume":"154","author":"Lopes-Nunes","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2022.213077_bb0235","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1039\/C7RA11116A","article-title":"AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells","volume":"8","author":"Ghahremani","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2022.213077_bb0240","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1038\/srep07851","article-title":"Aptamer-mediated up-conversion core\/MOF Shell nanocomposites for targeted drug delivery and cell imaging","volume":"5","author":"Deng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2022.213077_bb0245","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1039\/D0TB02527E","article-title":"Dynamics of delivering aptamer targeted nano-drugs into cells","volume":"9","author":"Liu","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioadv.2022.213077_bb0250","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/bm5001263","article-title":"AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy","volume":"15","author":"Lale","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bioadv.2022.213077_bb0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1440-1681.12670","article-title":"Smart bomb AS1411 aptamer-functionalized\/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer","volume":"44","author":"Barzegar Behrooz","year":"2017","journal-title":"Clin. Exp. Pharmacol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0260","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/0008-5472.CAN-17-2880","article-title":"Aptamer-conjugated extracellular nanovesicles for targeted drug delivery","volume":"78","author":"Wan","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioadv.2022.213077_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121209","article-title":"Dendrimer grafted persistent luminescent nanoplatform for aptamer guided tumor imaging and acid-responsive drug delivery","volume":"219","author":"Zhang","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.bioadv.2022.213077_bb0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0885328219882152","article-title":"Aptamer-guided upconversion nanoplatform for targeted drug delivery and near-infrared light-triggered photodynamic therapy","volume":"34","author":"Lin","year":"2020","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.bioadv.2022.213077_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jssc.2020.121680","article-title":"Aptamer-functionalized Fe3O4@MOF nanocarrier for targeted drug delivery and fluorescence imaging of the triple-negative MDA-MB-231 breast cancer cells","volume":"292","author":"Alijani","year":"2020","journal-title":"J. Solid State Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10856-019-6278-y","article-title":"Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy","volume":"30","author":"Sun","year":"2019","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.bioadv.2022.213077_bb0285","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1002\/smll.201202694","article-title":"An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells","volume":"9","author":"Zhao","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2022.213077_bb0290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.colsurfb.2018.07.008","article-title":"Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery","volume":"171","author":"Xu","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2022.213077_bb0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-065X.2002.18806.x","article-title":"Tumor-specific shared antigenic peptides recognized by human T cells","volume":"188","author":"Van Der Bruggen","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bioadv.2022.213077_bb0300","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ijc.29826","article-title":"An aptamer targeting shared tumor-specific peptide antigen of MAGE-A3 in multiple cancers","volume":"138","author":"Wang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioadv.2022.213077_bb0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15384047.2020.1833156","article-title":"Targeted drug delivery using an aptamer against shared tumor-specific peptide antigen of MAGE-A3","volume":"22","author":"Wang","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioadv.2022.213077_bb0310","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1021\/ja5079464","article-title":"Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells","volume":"136","author":"Oh","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2022.213077_bb0315","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ijbiomac.2020.09.166","article-title":"Chitosan\/carbon quantum dot\/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil","volume":"165","author":"Zavareh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.04.008","article-title":"Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery","volume":"400","author":"Taghavi","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2022.213077_bb0325","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1021\/acs.chemrev.5b00456","article-title":"Gated materials for on-command release of guest molecules","volume":"116","author":"Aznar","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioadv.2022.213077_bb0330","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.nano.2017.08.006","article-title":"MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications","volume":"13","author":"Pascual","year":"2017","journal-title":"nanomed.: nanotechnolBiol. Med."},{"key":"10.1016\/j.bioadv.2022.213077_bb0335","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1039\/C7TB01528C","article-title":"Aptamer-anchored di-polymer shell-capped mesoporous carbon as a drug carrier for bi-trigger targeted drug delivery","volume":"5","author":"Zhang","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioadv.2022.213077_bb0340","article-title":"Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro","volume":"7","author":"Hu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bioadv.2022.213077_bb0345","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/nano9071052","article-title":"Codelivery of genistein and miRNA-29b to A549 cells using aptamer-hybrid nanoparticle bioconjugates","volume":"9","author":"Sacko","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bioadv.2022.213077_bb0350","doi-asserted-by":"crossref","first-page":"87910","DOI":"10.1039\/C6RA19525C","article-title":"Aptamer mediated niosomal drug delivery","volume":"6","author":"Seleci","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2022.213077_bb0355","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/IJN.S149942","article-title":"Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells","volume":"13","author":"Shen","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213077_bb0360","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.2147\/IJN.S201688","article-title":"A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells","volume":"14","author":"Shen","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213077_bb0365","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1166\/jbn.2019.2694","article-title":"ATP aptamer-modified quantum dots with reduced Glutathione\/Adenosine triphosphate dual response features as a potential probe for intracellular drug delivery monitoring of vesicular nanocarriers","volume":"15","author":"Hu","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0370","doi-asserted-by":"crossref","first-page":"34050","DOI":"10.1021\/acsami.8b14009","article-title":"Cascaded aptamers-governed multistage drug-delivery system based on biodegradable envelope-type nanovehicle for targeted therapy of HER2-overexpressing breast cancer","volume":"10","author":"Liang","year":"2018","journal-title":"ACS. Appl. MaterInterfaces"},{"key":"10.1016\/j.bioadv.2022.213077_bb0375","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.nano.2012.01.010","article-title":"A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic","volume":"8","author":"Sundaram","year":"2012","journal-title":"nanomed.: nanotechnolBiol. Med."},{"key":"10.1016\/j.bioadv.2022.213077_bb0380","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1039\/D0AN00101E","article-title":"Extracellular pH-manipulated in situ reconfiguration of aptamer functionalized DNA monomer enables specifically improved affinity, detection and drug delivery","volume":"145","author":"Zou","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.bioadv.2022.213077_bb0385","doi-asserted-by":"crossref","first-page":"17048","DOI":"10.1002\/anie.201809753","article-title":"Self-assembled aptamer-grafted hyperbranched polymer nanocarrier for targeted and photoresponsive drug delivery","volume":"57","author":"Yang","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioadv.2022.213077_bb0390","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s00216-017-0238-5","article-title":"Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM","volume":"409","author":"Leitner","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0395","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/pr700894d","article-title":"Cell-specific aptamer probes for membrane protein elucidation in cancer cells","volume":"7","author":"Shangguan","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bioadv.2022.213077_bb0400","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jinorgbio.2013.07.021","article-title":"DNA-based aptamer fails as a simultaneous cancer targeting agent and drug delivery vehicle for a phenanthroline-based platinum(II) complex","volume":"128","author":"McGinely","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0405","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1002\/anie.201602702","article-title":"N-heterocyclic carbene-Gold(I) complexes conjugated to a leukemia-specific DNA aptamer for targeted drug delivery","volume":"55","author":"Niu","year":"2016","journal-title":"Angew. Chem. Int. ed. Engl."},{"key":"10.1016\/j.bioadv.2022.213077_bb0410","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/ja4117395","article-title":"Automated modular synthesis of aptamer-drug conjugates for targeted drug delivery","volume":"136","author":"Wang","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2022.213077_bb0415","first-page":"153","article-title":"An introduction to nanotechnology and drug delivery","volume":"5","author":"Hatami","year":"2021","journal-title":"Chem. Methodol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0420","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.matt.2020.11.002","article-title":"Integrating DNA nanotechnology with aptamers for biological and biomedical applications","volume":"4","author":"Huang","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.bioadv.2022.213077_bb0425","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1038\/srep10099","article-title":"A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2022.213077_bb0430","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fbioe.2020.00488","article-title":"Near infrared light triggered photo\/immuno-therapy toward cancers","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12274-015-0898-4","article-title":"Near-infrared light-activated cancer cell targeting and drug delivery with aptamer-modified nanostructures","volume":"9","author":"Yang","year":"2016","journal-title":"Nano Res."},{"key":"10.1016\/j.bioadv.2022.213077_bb0440","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1016\/j.biomaterials.2013.08.079","article-title":"A polyvalent aptamer system for targeted drug delivery","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2022.213077_bb0445","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/15384047.2021.1916381","article-title":"The role of CD133 in hepatocellular carcinoma","volume":"22","author":"Liu","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioadv.2022.213077_bb0450","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","article-title":"Cancer stem cells in hepatocellular carcinoma \u2014 from origin to clinical implications","volume":"19","author":"Lee","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0455","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2020.12.022","article-title":"An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells","volume":"501","author":"Zhou","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2022.213077_bb0460","first-page":"1864","article-title":"Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting","volume":"46","author":"Ma","year":"2018","journal-title":"artif. Cells nanomedBiotechnol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0465","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jiec.2019.01.023","article-title":"Conjugation of prostate cancer-specific aptamers to polyethylene glycol-grafted polyethylenimine for enhanced gene delivery to prostate cancer cells","volume":"73","author":"Lee","year":"2019","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.bioadv.2022.213077_bb0470","doi-asserted-by":"crossref","first-page":"9186583","DOI":"10.1155\/2020\/9186583","article-title":"Aptamer-conjugated multifunctional polymeric nanoparticles as cancer-targeted, MRI-ultrasensitive drug delivery systems for treatment of castration-resistant prostate cancer","volume":"2020","author":"Fang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioadv.2022.213077_bb0475","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","article-title":"Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?","volume":"39","author":"Gires","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioadv.2022.213077_bb0480","doi-asserted-by":"crossref","first-page":"165","DOI":"10.15698\/cst2019.06.188","article-title":"Biology and clinical relevance of EpCAM","volume":"3","author":"Keller","year":"2019","journal-title":"Cell stress"},{"key":"10.1016\/j.bioadv.2022.213077_bb0485","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejps.2015.12.014","article-title":"EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery","volume":"83","author":"Xie","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0490","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nano.2014.09.002","article-title":"Multifunctional nanoparticle-EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy","volume":"11","author":"Das","year":"2015","journal-title":"nanomed.: nanotechnolBiol. Med."},{"key":"10.1016\/j.bioadv.2022.213077_bb0495","first-page":"1083","article-title":"Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells","volume":"9","author":"Li","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2022.213077_bb0500","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioadv.2022.213077_bb0505","first-page":"576","article-title":"Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEXIran","volume":"18","author":"Moosavian","year":"2015","journal-title":"J. Basic. Med. Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0510","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2013the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2022.213077_bb0515","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.colsurfb.2015.12.009","article-title":"Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model","volume":"139","author":"Moosavian","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2022.213077_bb0520","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1002\/chem.201101403","article-title":"Aptamer-based switchable nanovalves for stimuli-responsive drug delivery","volume":"17","author":"\u00d6zalp","year":"2011","journal-title":"Chemistry"},{"key":"10.1016\/j.bioadv.2022.213077_bb0525","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/bkcs.10480","article-title":"Comparison of drug delivery efficiency between doxorubicin intercalated in RNA aptamer and one encapsulated in RNA aptamer-conjugated liposome","volume":"36","author":"Park","year":"2015","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.bioadv.2022.213077_bb0530","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2014.10.018","article-title":"RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo","volume":"196","author":"Baek","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2022.213077_bb0535","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/ijms17030380","article-title":"A RNA-DNA hybrid aptamer for nanoparticle-based prostate tumor targeted drug delivery","volume":"17","author":"Leach","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2022.213077_bb0540","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.37","article-title":"Dimeric DNA aptamer complexes for high-capacity-targeted drug delivery using pH-sensitive covalent linkages","volume":"2","author":"Boyacioglu","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bioadv.2022.213077_bb0545","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1002\/anie.200602251","article-title":"An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform","volume":"45","author":"Bagalkot","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioadv.2022.213077_bb0550","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/nl071546n","article-title":"Quantum Dot\u2212Aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer","volume":"7","author":"Bagalkot","year":"2007","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2022.213077_bb0555","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1021\/acsnano.5b05138","article-title":"Enhanced human epidermal growth factor receptor 2 degradation in breast cancer cells by lysosome-targeting gold nanoconstructs","volume":"9","author":"Lee","year":"2015","journal-title":"ACS Nano"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950822003545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950822003545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:42:53Z","timestamp":1757425373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950822003545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":111,"alternative-id":["S2772950822003545"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2022.213077","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in aptamer-based drug delivery vehicles for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2022.213077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"213077"}}